Overview
Nicole Mittmann practices in Toronto, Canada. Ms. Mittmann is highly rated in 5 conditions, according to our data. Her top areas of expertise are Febrile Neutropenia, Pancreatic Cancer, Breast Cancer, Fractured Spine, and Pancreaticoduodenectomy.
Her clinical research consists of co-authoring 181 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Febrile NeutropeniaMs. Mittmann isDistinguished. Learn about Febrile Neutropenia.
- Advanced
- Breast CancerMs. Mittmann isAdvanced. Learn about Breast Cancer.
- Fractured SpineMs. Mittmann isAdvanced. Learn about Fractured Spine.
- Pancreatic CancerMs. Mittmann isAdvanced. Learn about Pancreatic Cancer.
- PancreaticoduodenectomyMs. Mittmann isAdvanced. Learn about Pancreaticoduodenectomy.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Ms. Mittmann isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AgranulocytosisMs. Mittmann isExperienced. Learn about Agranulocytosis.
- Anal CancerMs. Mittmann isExperienced. Learn about Anal Cancer.
- B-Cell LymphomaMs. Mittmann isExperienced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Mittmann isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Mittmann isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).